| Primary |
| Hypertension |
27.5% |
| Product Used For Unknown Indication |
12.7% |
| Cerebrovascular Spasm |
8.5% |
| Drug Use For Unknown Indication |
7.7% |
| Prophylaxis |
7.0% |
| Vasospasm |
5.6% |
| Immunosuppression |
4.2% |
| Induction Of Anaesthesia |
4.2% |
| Tocolysis |
4.2% |
| Sedation |
3.5% |
| Tachycardia |
3.5% |
| Lung Disorder |
2.8% |
| Maintenance Of Anaesthesia |
2.1% |
| Threatened Labour |
2.1% |
| Blood Pressure Increased |
1.4% |
| Vasodilatation |
1.4% |
| Central Venous Catheterisation |
0.7% |
| Myasthenia Gravis |
0.7% |
|
| Blood Pressure Decreased |
22.4% |
| Hypoxia |
12.2% |
| Drug Interaction |
10.2% |
| Respiratory Distress |
8.2% |
| Drug Exposure During Pregnancy |
6.1% |
| Pneumonia |
6.1% |
| Bradycardia |
4.1% |
| Hypotension |
4.1% |
| Phlebitis |
4.1% |
| Angioedema |
2.0% |
| Blood Pressure Increased |
2.0% |
| Brain Oedema |
2.0% |
| Cardiac Arrest |
2.0% |
| Dizziness |
2.0% |
| Drug Ineffective |
2.0% |
| Dysuria |
2.0% |
| Glossoptosis |
2.0% |
| Heart Rate Increased |
2.0% |
| Hepatitis Acute |
2.0% |
| Hydrocephalus |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
37.4% |
| Hypertension |
17.1% |
| Drug Use For Unknown Indication |
11.7% |
| Prophylaxis |
8.0% |
| Embolic Stroke |
4.0% |
| Infection |
2.4% |
| Tocolysis |
2.0% |
| Epilepsy |
1.9% |
| Pyrexia |
1.7% |
| Anxiety |
1.6% |
| Cardiac Failure |
1.6% |
| Immunosuppression |
1.6% |
| Constipation |
1.3% |
| Insomnia |
1.3% |
| Pain |
1.3% |
| Diabetes Mellitus |
1.2% |
| Arrhythmia |
1.1% |
| Breast Cancer |
1.0% |
| Premedication |
1.0% |
| Anaesthesia |
0.9% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
15.1% |
| Phlebitis |
14.0% |
| Fall |
6.5% |
| Thrombotic Microangiopathy |
6.5% |
| Cytolytic Hepatitis |
5.4% |
| Premature Baby |
5.4% |
| Coma |
4.3% |
| Drug Interaction |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Maternal Exposure During Pregnancy |
4.3% |
| Pain In Extremity |
4.3% |
| Pyrexia |
4.3% |
| Thrombocytopenia |
4.3% |
| Dyspnoea |
3.2% |
| Tubulointerstitial Nephritis |
3.2% |
| Cardiac Arrest |
2.2% |
| Cerebral Haematoma |
2.2% |
| Consciousness Fluctuating |
2.2% |
| Duodenal Ulcer |
2.2% |
| Hemiparesis |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.1% |
| Hypertension |
19.5% |
| Product Used For Unknown Indication |
15.2% |
| Pain |
5.6% |
| Prophylaxis |
5.3% |
| Hiv Infection |
4.2% |
| Diabetes Mellitus |
3.8% |
| Multiple Myeloma |
3.6% |
| Sedation |
3.3% |
| Nausea |
3.0% |
| Myocardial Ischaemia |
2.4% |
| Anxiety |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Hepatitis C |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Renal Transplant |
1.5% |
| Agitation |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Constipation |
1.3% |
|
| Renal Failure |
15.3% |
| Thrombocytopenia |
9.7% |
| Renal Failure Acute |
6.9% |
| Vomiting |
6.3% |
| Cerebral Haemorrhage |
4.9% |
| Haematoma |
4.9% |
| Pancreatitis Acute |
4.9% |
| Pyrexia |
4.9% |
| Tachycardia |
4.9% |
| Cerebral Infarction |
4.2% |
| Respiratory Failure |
4.2% |
| Hyponatraemia |
3.5% |
| Injury |
3.5% |
| Moaning |
3.5% |
| Off Label Use |
3.5% |
| Pneumonia Aspiration |
3.5% |
| Renal Impairment |
3.5% |
| Cardio-respiratory Arrest |
2.8% |
| Hypertension |
2.8% |
| Oesophagitis Ulcerative |
2.8% |
|
| Interacting |
| Induction Of Anaesthesia |
30.2% |
| Hypertension |
18.9% |
| Tachycardia |
18.9% |
| Subarachnoid Haemorrhage |
13.2% |
| Maintenance Of Anaesthesia |
9.4% |
| Sedation |
7.5% |
| Sedative Therapy |
1.9% |
|
| Cardiac Arrest |
46.2% |
| Drug Interaction |
15.4% |
| Hypoxia |
15.4% |
| Sinus Arrest |
15.4% |
| Overdose |
7.7% |
|
